5-methoxy-alpha-methyltryptamine has been researched along with ketanserin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abiero, A; Botanas, CJ; Chang, CM; Cheong, JH; Custodio, RJ; de la Peña, JB; Jang, CG; Kim, HJ; Kim, M; Lee, HJ; Lee, YS; Ryu, IS; Sayson, LV; Seo, JW; Yang, JS | 1 |
1 other study(ies) available for 5-methoxy-alpha-methyltryptamine and ketanserin
Article | Year |
---|---|
5-Methoxy-α-methyltryptamine (5-MeO-AMT), a tryptamine derivative, induces head-twitch responses in mice through the activation of serotonin receptor 2a in the prefrontal cortex.
Topics: Animals; Conditioning, Operant; Dose-Response Relationship, Drug; Gene Expression Regulation; Head Movements; Ketanserin; Locomotion; Male; Mice; Mice, Inbred C57BL; Prefrontal Cortex; Protein Kinases; Receptor, Serotonin, 5-HT2A; RNA, Messenger; Self Administration; Serotonin; Serotonin Agents | 2019 |